抗逆转录病毒疗法与血脂异常：破解密码
Antiretroviral therapy and dyslipidaemia: unlocking the code.
作者信息
Mallon Patrick W G
机构信息
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, St. Vincent's Medical Centre, Sydney, Australia. p.mallon@cfi .unsw.edu.au
出版信息
PLoS Med. 2006 Mar;3(3):e85. doi: 10.1371/journal.pmed.0030085. Epub 2006 Jan 24.
Abstract
Mallon discusses a new study that describes associations between apoC-III polymorphisms and triglyceride concentrations in a large population of HIV-infected patients from a variety of ethnic backgrounds.
摘要
马伦讨论了一项新研究，该研究描述了来自不同种族背景的大量HIV感染患者中载脂蛋白C-III基因多态性与甘油三酯浓度之间的关联。
相似文献
1
Antiretroviral therapy and dyslipidaemia: unlocking the code.抗逆转录病毒疗法与血脂异常：破解密码
PLoS Med. 2006 Mar;3(3):e85. doi: 10.1371/journal.pmed.0030085. Epub 2006 Jan 24.
2
Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in triglyceride-rich lipoproteins.对HIV阳性男性进行抗逆转录病毒治疗与富含甘油三酯的脂蛋白中载脂蛋白CIII增加有关。
HIV Med. 2005 Sep;6(5):326-33. doi: 10.1111/j.1468-1293.2005.00316.x.
3
Antiretroviral treatment-induced dyslipidemia in HIV-infected patients is influenced by the APOC3-related rs10892151 polymorphism.抗逆转录病毒治疗引起的 HIV 感染患者的血脂异常受 APOC3 相关 rs10892151 多态性影响。
BMC Med Genet. 2011 Sep 22;12:120. doi: 10.1186/1471-2350-12-120.
4
Polymorphisms of the ApoE (Apolipoprotein E) gene and their influence on dyslipidemia in HIV-1-infected individuals.载脂蛋白E（ApoE）基因多态性及其对HIV-1感染个体血脂异常的影响。
Jpn J Infect Dis. 2015;68(1):5-12. doi: 10.7883/yoken.JJID.2013.190. Epub 2014 Nov 25.
5
[Pharmacogenetics of antiretroviral drugs].
Vojnosanit Pregl. 2012 Dec;69(12):1091-6. doi: 10.2298/vsp1212091d.
6
Adipokine profiles and lipodystrophy in HIV-infected children during the first 4 years on highly active antiretroviral therapy.在接受高效抗逆转录病毒治疗的前 4 年中，HIV 感染儿童的脂肪因子谱和脂肪营养不良。
HIV Med. 2011 Jan;12(1):54-60. doi: 10.1111/j.1468-1293.2010.00837.x.
7
[Pharmacogenetics of antiretroviral therapy 2008: toward personalized treatment?].《2008年抗逆转录病毒疗法的药物遗传学：迈向个性化治疗？》
Enferm Infecc Microbiol Clin. 2008 May;26 Suppl 6:1-3. doi: 10.1016/s0213-005x(08)76505-4.
8
Short communication: Lipids and cardiovascular risk after switching HIV-1 patients on nevirapine and emtricitabine/tenofovir-DF to rilpivirine/emtricitabine/tenofovir-DF.简短通讯：将接受奈韦拉平与恩曲他滨/替诺福韦酯治疗的HIV-1患者换用利匹韦林/恩曲他滨/替诺福韦酯后的脂质与心血管风险
AIDS Res Hum Retroviruses. 2015 Apr;31(4):363-7. doi: 10.1089/AID.2014.0278. Epub 2015 Feb 26.
9
引用本文的文献
1
Association of the polymorphisms of the genes APOC3 (rs2854116), ESR2 (rs3020450), HFE (rs1799945), MMP1 (rs1799750) and PPARG (rs1801282) with lipodystrophy in people living with HIV on antiretroviral therapy: a systematic review.载脂蛋白 C3（rs2854116）、雌激素受体 2（rs3020450）、HFE（rs1799945）、基质金属蛋白酶 1（rs1799750）和过氧化物酶体增殖物激活受体 γ（rs1801282）基因多态性与接受抗逆转录病毒治疗的 HIV 感染者脂肪营养不良的相关性：系统评价。
Mol Biol Rep. 2020 Jun;47(6):4779-4787. doi: 10.1007/s11033-020-05441-3. Epub 2020 Apr 22.
2
HIV replication enhances production of free fatty acids, low density lipoproteins and many key proteins involved in lipid metabolism: a proteomics study.一项蛋白质组学研究表明，HIV复制会增强游离脂肪酸、低密度脂蛋白以及许多参与脂质代谢的关键蛋白质的生成。
PLoS One. 2008 Aug 20;3(8):e3003. doi: 10.1371/journal.pone.0003003.
本文引用的文献
1
Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy.接受抗逆转录病毒治疗的HIV-1感染者的种族/族裔、载脂蛋白C-III基因型与血脂之间的关联。
PLoS Med. 2006 Mar;3(3):e52. doi: 10.1371/journal.pmed.0030052.
2
Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in triglyceride-rich lipoproteins.对HIV阳性男性进行抗逆转录病毒治疗与富含甘油三酯的脂蛋白中载脂蛋白CIII增加有关。
HIV Med. 2005 Sep;6(5):326-33. doi: 10.1111/j.1468-1293.2005.00316.x.
3
Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients.细胞色素P450 2B6基因多态性对HIV感染患者中依非韦伦和奈韦拉平的血浆及细胞内浓度和毒性的影响。
Pharmacogenet Genomics. 2005 Jan;15(1):1-5. doi: 10.1097/01213011-200501000-00001.
4
In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA.在体内，核苷类逆转录酶抑制剂在不消耗线粒体DNA的情况下改变线粒体和脂质代谢基因的表达。
J Infect Dis. 2005 May 15;191(10):1686-96. doi: 10.1086/429697. Epub 2005 Apr 12.
5
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.模拟载脂蛋白C3、载脂蛋白E和肿瘤坏死因子基因多态性对抗逆转录病毒治疗相关脂质紊乱风险的影响。
J Infect Dis. 2005 May 1;191(9):1419-26. doi: 10.1086/429295. Epub 2005 Mar 22.
6
The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk.载脂蛋白A1/C3/A4/A5基因簇、脂质代谢与心血管疾病风险
Curr Opin Lipidol. 2005 Apr;16(2):153-66. doi: 10.1097/01.mol.0000162320.54795.68.
7
Cardiovascular risk and body-fat abnormalities in HIV-infected adults.HIV感染成人的心血管风险与体脂异常
N Engl J Med. 2005 Jan 6;352(1):48-62. doi: 10.1056/NEJMra041811.
8
9
Combination antiretroviral therapy and the risk of myocardial infarction.联合抗逆转录病毒疗法与心肌梗死风险
N Engl J Med. 2003 Nov 20;349(21):1993-2003. doi: 10.1056/NEJMoa030218.
10
A multi-investigator/institutional DNA bank for AIDS-related human genetic studies: AACTG Protocol A5128.一个用于艾滋病相关人类基因研究的多研究者/机构DNA库：AACTG方案A5128。
HIV Clin Trials. 2003 Sep-Oct;4(5):287-300. doi: 10.1310/MUQC-QXBC-8118-BPM5.
Zotero 插件